國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug discovery and drug developmentt...

Dikshit, Madhu.

Drug discovery and drug developmentthe Indian narrative /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug discovery and drug developmentedited by Madhu Dikshit.
其他題名:	the Indian narrative /
其他作者:	Dikshit, Madhu.
出版者:	Singapore :Springer Singapore :2021.
面頁冊數:	xiii, 376 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Drug developmentIndia.
電子資源:	https://doi.org/10.1007/978-981-15-8002-4
ISBN:	9789811580024$q(electronic bk.)

Drug discovery and drug developmentthe Indian narrative /
Drug discovery and drug developmentthe Indian narrative /[electronic resource] :edited by Madhu Dikshit. - Singapore :Springer Singapore :2021. - xiii, 376 p. :ill., digital ;24 cm.

Chapter 1. Traditional Medical System (TMS) for Sustainable Healthcare in India -- Chapter 2. Modern Drug Discovery and Development for TB- The India Narrative -- Chapter 3. Indian Discovery Effort in the Quest of Novel Antibiotics -- Chapter 4. New Drug Discovery and Development in India to Counter Malaria -- Chapter 5. Modern Drug Discovery and Development in the area of Leishmaniasis -- Chapter 6. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part I - Introduction to Diabetes and Prevalence in India -- Chapter 7. Modern Drug Discovery and Development: Diabetes and lifestyle disorder Part II Type 2 Diabetes Mellitus: Marketed drugs and mechanisms -- Chapter 8. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part III Anti-diabetes research in India: Contributions from industrial organizations -- Chapter 9. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part IV Indian Academia Tryst with Cardio-metabolic Drug Discovery and Development -- Chapter 10. Modern drug discovery and development in the area of Cancer: Indian context -- Chapter 11. Biopharmaceutical development in India: recommendations on collaboration and innovation to enable affordable healthcare -- Chapter 12. Regulatory requirements and Quality Standards in India's Clinical Trials Journey -- Chapter 13. Indian Pharma Perspective: New Drug Discovery and Development- Indian Pharmaceutical Industry.

Over the years, India has attained a prominent global position in the manufacture of Generic Drugs. This success can be attributed to its synthetic organic chemistry and chemical engineering strengths, nurtured by the timely policies of the Government of India. However, breakthrough successes in New Drug Discovery have remained elusive, despite the brilliant and sustained efforts of many Indian researchers and Pharma establishments. The Indian National Science Academy thought it appropriate to document India's New Drug Discovery Research (NDDR) journey to date. Gathering contributions from prominent researchers in the Indian Pharma Industry and Academia, this book highlights their efforts, achievements, and the status quo of Indian NDDR.

ISBN: 9789811580024$q(electronic bk.)

Standard No.: 10.1007/978-981-15-8002-4doiSubjects--Topical Terms:

894516
Drug development
--India.

LC Class. No.: RM301.25

Dewey Class. No.: 615.19

Drug discovery and drug developmentthe Indian narrative /
LDR:03195nmm a2200325 a 4500 001 600063
003 DE-He213
005 20210419164652.0
006 m d
007 cr nn 008maaau
008 211104s2021 si s 0 eng d
020 $a 9789811580024$q(electronic bk.)
020 $a 9789811580017$q(paper)
024 7 $a 10.1007/978-981-15-8002-4 $2 doi
035 $a 978-981-15-8002-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.25
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.19 $2 23
090 $a RM301.25 $b .D794 2021
245 0 0 $a Drug discovery and drug development $h [electronic resource] : $b the Indian narrative / $c edited by Madhu Dikshit.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a xiii, 376 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Traditional Medical System (TMS) for Sustainable Healthcare in India -- Chapter 2. Modern Drug Discovery and Development for TB- The India Narrative -- Chapter 3. Indian Discovery Effort in the Quest of Novel Antibiotics -- Chapter 4. New Drug Discovery and Development in India to Counter Malaria -- Chapter 5. Modern Drug Discovery and Development in the area of Leishmaniasis -- Chapter 6. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part I - Introduction to Diabetes and Prevalence in India -- Chapter 7. Modern Drug Discovery and Development: Diabetes and lifestyle disorder Part II Type 2 Diabetes Mellitus: Marketed drugs and mechanisms -- Chapter 8. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part III Anti-diabetes research in India: Contributions from industrial organizations -- Chapter 9. Modern Drug Discovery and Development: Diabetes and lifestyle disorders Part IV Indian Academia Tryst with Cardio-metabolic Drug Discovery and Development -- Chapter 10. Modern drug discovery and development in the area of Cancer: Indian context -- Chapter 11. Biopharmaceutical development in India: recommendations on collaboration and innovation to enable affordable healthcare -- Chapter 12. Regulatory requirements and Quality Standards in India's Clinical Trials Journey -- Chapter 13. Indian Pharma Perspective: New Drug Discovery and Development- Indian Pharmaceutical Industry.
520 $a Over the years, India has attained a prominent global position in the manufacture of Generic Drugs. This success can be attributed to its synthetic organic chemistry and chemical engineering strengths, nurtured by the timely policies of the Government of India. However, breakthrough successes in New Drug Discovery have remained elusive, despite the brilliant and sustained efforts of many Indian researchers and Pharma establishments. The Indian National Science Academy thought it appropriate to document India's New Drug Discovery Research (NDDR) journey to date. Gathering contributions from prominent researchers in the Indian Pharma Industry and Academia, this book highlights their efforts, achievements, and the status quo of Indian NDDR.
650 0 $a Drug development $z India. $3 894516
650 0 $a Pharmaceutical industry $z India. $3 619150
650 1 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Biotechnology. $3 188829
650 2 4 $a Biomedicine, general. $3 853300
700 1 $a Dikshit, Madhu. $3 894515
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-15-8002-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)